Advertisement

Topics

Medopad, a UK Healthcare App, Signs $140 Million of Deals in China

23:56 EST 1 Feb 2018 | ChinaBio Today

Medopad, a UK AI mobile healthcare app, signed 15 contracts with China companies that have a total value of over $140 million. Medopad combines AI with patient records for doctors and remote monitoring among its many services. The partnerships included a collaboration with Tencent Holdings to use AI to support doctors’ decision-making, plus other agreements with China Resources, Ping An Good Doctor, Peking University, Lenovo New Vision and GSK China. Medopad officials were part of a UK trade mission to China led by Prime Minister Theresa May. More details....

Share this with colleagues:

Original Article: Medopad, a UK Healthcare App, Signs $140 Million of Deals in China

NEXT ARTICLE

More From BioPortfolio on "Medopad, a UK Healthcare App, Signs $140 Million of Deals in China"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.